Prenetics Global Limited (NASDAQ: PRE) announced a multi-year partnership with actress and producer Lily Collins, naming her a Global Ambassador for its IM8 health brand and a shareholder in Prenetics.

Collins, who received two Golden Globe nominations and stars in Netflix's Emily in Paris, becomes the first IM8 ambassador from film and television. Previous ambassadors have come from sports and wellness, including co-founder David Beckham, NBA player Giannis Antetokounmpo, tennis player Aryna Sabalenka, Formula 1 driver Ollie Bearman, and author Jay Shetty. Like prior ambassadors, Collins receives equity in Prenetics as part of the deal.

According to the company's statement, Collins began using IM8's Daily Ultimate Essentials product in late 2025 after a physician recommendation while she was filming. The partnership was formalized following months of personal use.

Collins has more than 33 million followers across social platforms, including over 28 million on Instagram, with an engagement rate of approximately 5.9%.

Alongside the ambassador announcement, Prenetics raised its full-year 2026 revenue guidance to $220–$230 million and initiated full-year 2027 revenue guidance of $400 million or more. The company said it achieved positive consolidated Adjusted Free Cash Flow in July 2026 and expects to maintain that position through the third quarter of 2026 and beyond.

IM8's flagship product, Daily Ultimate Essentials, launched in December 2024 and has since delivered more than 57 million servings. The brand currently ships approximately 200,000 servings per day to 46 countries, with 54% of revenue generated outside the United States. New products include IM8 Hydration, planned for Q4 2026, and a gummies line expected in the first half of 2027.

Collins will appear in IM8's global marketing campaigns, brand content, and product initiatives.